Cargando…

ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A

Bladder cancer is one of the most common malignant tumors in the urinary system. The development and improvement of treatment efficiency require the deepening of the understanding of its molecular mechanism. This study investigated the role of ALPK2, which is rarely studied in malignant tumors, in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuchen, Wu, Jie, Luo, Wenjie, Zhang, Hailiang, Shi, Guohai, Shen, Yijun, Zhu, Yao, Ma, Chunguang, Dai, Bo, Ye, Dingwei, Zhu, Yiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249393/ https://www.ncbi.nlm.nih.gov/pubmed/34210956 http://dx.doi.org/10.1038/s41419-021-03947-7

Ejemplares similares

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
por: Wu, Junlong, et al.
Publicado: (2017)

Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma
por: Fangning, Wan, et al.
Publicado: (2017)

Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study
por: Qin, Xiaojian, et al.
Publicado: (2015)

Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis
por: Wang, Beihe, et al.
Publicado: (2018)

Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma
por: Wang, Beihe, et al.
Publicado: (2017)

AB032. Penile rehabilitation using Vacuum Erection Device for erectile dysfunction after radical prostatectomy
por: Ye, Dingwei, et al.
Publicado: (2015)

DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1
por: Lai, Chin-Hui, et al.
Publicado: (2020)

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer
por: Abudurexiti, MierXiati, et al.
Publicado: (2019)

Outcomes of patients with lymph node metastasis treated with radical prostatectomy and adjuvant androgen deprivation therapy in a Chinese population: results from a cohort study
por: Qin, Xiaojian, et al.
Publicado: (2015)

NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer
por: Wu, Junlong, et al.
Publicado: (2017)

Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
por: Wan, Fangning, et al.
Publicado: (2015)

PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness
por: Chang, Kun, et al.
Publicado: (2017)

Extramammary Paget’s diseases in men from the Shanghai area: its association with PSA level increase*
por: SHI, GUOHAI, et al.
Publicado: (2010)

ACSL4 Expression Is Associated With CD8+ T Cell Infiltration and Immune Response in Bladder Cancer
por: Luo, Wenjie, et al.
Publicado: (2021)

Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma
por: Wang, Hongkai, et al.
Publicado: (2016)

Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients
por: Wu, Junlong, et al.
Publicado: (2017)

Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
por: Jin, Shengming, et al.
Publicado: (2018)

LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer
por: Luo, Wenjie, et al.
Publicado: (2021)

PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway
por: Wang, HongKai, et al.
Publicado: (2017)

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2018)

The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2017)

Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer
por: Wan, Fangning, et al.
Publicado: (2014)

B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
por: Qin, Xiaojian, et al.
Publicado: (2013)

High expression of F2RL3 correlates with aggressive features and poor survival in clear cell renal cell carcinoma
por: Cao, Dalong, et al.
Publicado: (2018)

Inherited mutations in Chinese patients with upper tract urothelial carcinoma
por: Wu, Junlong, et al.
Publicado: (2023)

Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer
por: Bian, Xiaojie, et al.
Publicado: (2015)

Log Odds Could Better Predict Survival in Muscle-Invasive Bladder Cancer Patients Compared with pN and Lymph Node Ratio
por: Jin, Shengming, et al.
Publicado: (2019)

Knockdown of ALPK2 inhibits the development and progression of Ovarian Cancer
por: Zhu, Xiaogang, et al.
Publicado: (2020)

Complicated variation of simple renal cyst usually means malignancy: results from a cohort study
por: Qin, XiaoJian, et al.
Publicado: (2014)

The Involvement of ALPK3 in Hypertrophic Cardiomyopathy in East Asia
por: Dai, Jiaqi, et al.
Publicado: (2022)

Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib
por: Lu, Xiaolin, et al.
Publicado: (2016)

SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression
por: Ma, Jian, et al.
Publicado: (2018)

Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data
por: Tian, Xi, et al.
Publicado: (2020)

Prognostic Value of Components of Body Composition in Patients Treated with Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Case Series
por: Gu, Weijie, et al.
Publicado: (2015)

Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients
por: Gu, Weijie, et al.
Publicado: (2017)

Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer
por: Qu, Yuanyuan, et al.
Publicado: (2015)

In vitro kinase assay reveals ADP-heptose-dependent ALPK1 autophosphorylation and altered kinase activity of disease-associated ALPK1 mutants
por: García-Weber, Diego, et al.
Publicado: (2023)

TERT Core Promotor Mutations in Early-Onset Bladder Cancer
por: Giedl, Johannes, et al.
Publicado: (2016)

MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation
por: Zhang, Zhen, et al.
Publicado: (2019)

Interleukin-20 Acts as a Promotor of Osteoclastogenesis and Orthodontic Tooth Movement
por: Liu, Yuanbo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qsle22qct81risnlnms6u3s1h6